Revolution Medicines Inc Warrant
RVMDW
23 hedge funds and large institutions have $18.1M invested in Revolution Medicines Inc Warrant in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
118% more capital invested
Capital invested by funds: $8.31M → $18.1M (+$9.79M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
12.2% more ownership
Funds ownership: 78.97% → 91.16% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 24 → 23 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$1.51M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$1.33M |
| 3 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$809K |
| 4 |
D.E. Shaw & Co
New York
|
+$243K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$30.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soros Capital Management
New York
|
-$343K |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$223K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$217K |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$80K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31.7K |
RVMDW Hedge Fund Activity: Q1 2026 in Review
23 of the 8,198 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q1 2026, worth a combined $18.1M — up 118% from $8.31M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RVMDW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Sculptor Capital, adding an estimated $1.51M. The largest seller was Soros Capital Management, exiting entirely with an estimated $343K sold.
- 23 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q1 2026, down from 24 in Q4 2025.
- Funds reported $18.1M of Revolution Medicines Inc Warrant stock for Q1 2026, up 118% quarter-over-quarter.
- 2 funds opened new Revolution Medicines Inc Warrant positions in Q1 2026 and 3 closed out, a net change of -1 holder.
- The largest Revolution Medicines Inc Warrant buyer in Q1 2026 was Sculptor Capital, an estimated $1.51M added.
- The largest Revolution Medicines Inc Warrant seller in Q1 2026 was Soros Capital Management, an estimated $343K sold.
Based on aggregated 13F filings for Q1 2026.